ID   DQA1_HUMAN              Reviewed;         254 AA.
AC   P01909; O19630; O19706; P01907; P01908; P04225; P04226; P05536;
AC   P79553; Q06751; Q29876; Q29994; Q2Q6Y6; Q2Q6Y7; Q2Q6Y8; Q2WCM3;
AC   Q30064; Q30067; Q30068; Q30070; Q30071; Q30072; Q30073; Q30086;
AC   Q30101; Q5Y7D5; Q5Y7F5; Q6ICU6; Q6PR46; Q6QDB1; Q860W2; Q860W4;
AC   Q9BD37; Q9TPM3; Q9UM31;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   22-JUL-2015, entry version 151.
DE   RecName: Full=HLA class II histocompatibility antigen, DQ alpha 1 chain;
DE   AltName: Full=DC-1 alpha chain;
DE   AltName: Full=DC-alpha;
DE   AltName: Full=HLA-DCA;
DE   AltName: Full=MHC class II DQA1;
DE   Flags: Precursor;
GN   Name=HLA-DQA1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*02:01).
RX   PubMed=6415485; DOI=10.1038/305813a0;
RA   Chang H.-C., Moriuchi T., Silver J.;
RT   "The heavy chain of human B-cell alloantigen HLA-DS has a variable N-
RT   terminal region and a constant immunoglobulin-like region.";
RL   Nature 305:813-815(1983).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).
RX   PubMed=6585297;
RA   Schenning L., Larhammar D., Bill P., Wiman K., Jonsson A.-K., Rask L.,
RA   Peterson P.A.;
RT   "Both alpha and beta chains of HLA-DC class II histocompatibility
RT   antigens display extensive polymorphism in their amino-terminal
RT   domains.";
RL   EMBO J. 3:447-452(1984).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELES DQA1*01:02 AND ALLELE DQA1*03:01).
RX   PubMed=6584734; DOI=10.1038/308327a0;
RA   Auffray C., Lillie J.W., Arnot D., Grossberger D., Kappes D.,
RA   Strominger J.L.;
RT   "Isotypic and allotypic variation of human class II histocompatibility
RT   antigen alpha-chain genes.";
RL   Nature 308:327-333(1984).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ALLELE DQA1*05:01).
RX   PubMed=3584986;
RA   Schiffenbauer J., Didier D.K., Klearman M., Rice K., Shuman S.,
RA   Tieber V.L., Kittlesen D.J., Schwartz B.D.;
RT   "Complete sequence of the HLA DQ alpha and DQ beta cDNA from a
RT   DR5/DQw3 cell line.";
RL   J. Immunol. 139:228-233(1987).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*05:01).
RX   PubMed=9271631; DOI=10.1007/s002510050295;
RA   Ellis M.C., Hetisimer A.H., Ruddy D.A., Hansen S.L., Kronmal G.S.,
RA   McClelland E., Quintana L., Drayna D.T., Aldrich M.S., Mignot E.;
RT   "HLA class II haplotype and sequence analysis support a role for DQ in
RT   narcolepsy.";
RL   Immunogenetics 46:410-417(1997).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:01; DQA1*01:02 AND
RP   DQA1*03:01).
RX   PubMed=16140993; DOI=10.1101/gr.3554305;
RA   Raymond C.K., Kas A., Paddock M., Qiu R., Zhou Y., Subramanian S.,
RA   Chang J., Palmieri A., Haugen E., Kaul R., Olson M.V.;
RT   "Ancient haplotypes of the HLA Class II region.";
RL   Genome Res. 15:1250-1257(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02; DQA1*05:06;
RP   DQA1*05:07 AND DQA1*05:08).
RX   PubMed=16866887; DOI=10.1111/j.1399-0039.2006.00645.x;
RA   Lee K.W., Jung Y.A., Oh D.H.;
RT   "Four novel human leukocyte antigen-DQA1 alleles identified in the
RT   Korean population.";
RL   Tissue Antigens 68:167-172(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*03:01).
RX   PubMed=3036828;
RA   Jonsson A.-K., Hyldig-Nielsen J.-J., Servenius B., Larhammar D.,
RA   Andersson G., Joergensen F., Peterson P.A., Rask L.;
RT   "Class II genes of the human major histocompatibility complex.
RT   Comparisons of the DQ and DX alpha and beta genes.";
RL   J. Biol. Chem. 262:8767-8777(1987).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELE DQA1*01:01).
RA   Ashdown M.L., Leas L., Gavrilidis A., Wood J.M., Simons M.J.;
RT   "Identification of a novel DQA1 allele, DQA1*01012, and confirmatory
RT   sequence of DQA1*01011.";
RL   Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*02:01).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ALLELES DQA1*01:02 AND DQA1*05:09).
RA   Voorter C.E., van den Berg-Loonen E.M.;
RT   "New and confirmatory HLA sequences by SBT.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELE DQA1*01:01).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA] (ALLELES DQA1*01:02;
RP   DQA1*03:01 AND DQA1*05:01).
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ALLELES DQA1*03:01 AND
RP   DQA1*05:01).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-27 (ALLELES
RP   DQA1*01:01/DQA1*01:02/DQA1*01:03; DQA1*01:04; DQA1*01:05;
RP   DQA1*02:01/DQA1*03:01/DQA1*03:03; DQA1*04:01/DQA1*06:01 AND
RP   DQA1*05:01/DQA1*05:03/DQA1*05:05).
RC   TISSUE=B-cell;
RA   Yasunaga S., Kimura A., Sasazuki T.;
RT   "Sequence polymorphisms in HLA-DQA1 exon1.";
RL   Submitted (JUL-1996) to the EMBL/GenBank/DDBJ databases.
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 19-254 (ALLELE DQA1*03:02).
RX   PubMed=3879967; DOI=10.1073/pnas.82.10.3420;
RA   Moriuchi J., Moriuchi T., Silver J.;
RT   "Nucleotide sequence of an HLA-DQ alpha chain derived from a DRw9 cell
RT   line: genetic and evolutionary implications.";
RL   Proc. Natl. Acad. Sci. U.S.A. 82:3420-3424(1985).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 23-254 (ALLELE DQA1*01:02).
RX   PubMed=3259543; DOI=10.1007/BF00364432;
RA   Lock C.B., So A.K., Welsh K.I., Parkes J.D., Trowsdale J.;
RT   "MHC class II sequences of an HLA-DR2 narcoleptic.";
RL   Immunogenetics 27:449-455(1988).
RN   [18]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-250 (ALLELE DQA1*03:02/DQA1*03:03)
RP   AND NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELES DQA1*01:01;
RP   DQA1*01:03; DQA1*01:04; DQA1*04:01; DQA1*05:03; DQA1*05:05 AND
RP   DQA1*06:01).
RX   PubMed=8929711; DOI=10.1111/j.1399-0039.1996.tb02512.x;
RA   Yasunaga S., Kimura A., Hamaguchi K., Ronningen K.S., Sasazuki T.;
RT   "Different contribution of HLA-DR and -DQ genes in susceptibility and
RT   resistance to insulin-dependent diabetes mellitus (IDDM).";
RL   Tissue Antigens 47:37-48(1996).
RN   [19]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-249 (ALLELE DQA1*01:05).
RA   Yasunaga S.;
RL   Submitted (JAN-1996) to the EMBL/GenBank/DDBJ databases.
RN   [20]
RP   PROTEIN SEQUENCE OF 24-89; 102-120 AND 164-212 (ALLELE DQA1*01:02).
RX   PubMed=6576979;
RA   Goetz H., Kratzin H., Thinnes F.P., Yang C.-Y., Kruse T., Pauly E.,
RA   Koelbel S., Egert G., Wernet P., Hilschmann N.;
RT   "Primary structure of human class II histocompatibility antigens 3rd
RT   communication. Amino acid sequence comparison between DR and DC
RT   subclass antigens derived from a lymphoblastoid B cell line homozygous
RT   at the HLA loci (HLA-A3,3; B7,7; Dw2,2; DR2,2: MT1,1; Dc1,1: MB1,1).";
RL   Hoppe-Seyler's Z. Physiol. Chem. 364:749-755(1983).
RN   [21]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 24-209 (ALLELE DQA1*05:01).
RX   PubMed=2493052;
RA   Kao H.T., Gregersen P.K., Tang J.C., Takahashi T., Wang C.Y.,
RA   Silver J.;
RT   "Molecular analysis of the HLA class II genes in two DRw6-related
RT   haplotypes, DRw13 DQw1 and DRw14 DQw3.";
RL   J. Immunol. 142:1743-1747(1989).
RN   [22]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELES DQA1*04:02 AND
RP   DQA1*04:04).
RX   PubMed=15853899; DOI=10.1111/j.1399-0039.2005.00389.x;
RA   Cordovado S.K., Hancock L.N., Simone A.E., Hendrix M., Mueller P.W.;
RT   "High-resolution genotyping of HLA-DQA1 in the GoKinD study and
RT   identification of novel alleles HLA-DQA1*040102, HLA-DQA1*0402 and
RT   HLA-DQA1*0404.";
RL   Tissue Antigens 65:448-458(2005).
RN   [23]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*06:02).
RA   Simone A.E., Cordovado S.K., Hendrix M.M., Mueller P.W.;
RT   "Identification of a novel HLA-DQA1*06 allele detected by sequence-
RT   based typing.";
RL   Submitted (DEC-2002) to the EMBL/GenBank/DDBJ databases.
RN   [24]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-203 (ALLELE DQA1*01:07).
RA   Hancock L.N., Cordovado S.K., Mueller P.W.;
RT   "Identification of a novel HLA-DQA1*01 allele detected by sequence-
RT   based typing.";
RL   Submitted (MAR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [25]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-110 (ALLELE DQA1*01:02), AND
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:01).
RX   PubMed=3372263; DOI=10.1016/0198-8859(88)90034-1;
RA   Horn G.T., Bugawan T.L., Long C.M., Manos M.M., Erlich H.A.;
RT   "Sequence analysis of HLA class II genes from insulin-dependent
RT   diabetic individuals.";
RL   Hum. Immunol. 21:249-263(1988).
RN   [26]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 29-109 (ALLELE DQA1*05:04).
RA   Trejaut J.A., Greville W.D., Dunckley H.;
RT   "DQA1 subtyping in Australian Aborigines. Additional evidence for
RT   heterogeneity.";
RL   Submitted (JAN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [27]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 31-109 (ALLELE DQA1*01:06).
RX   PubMed=10395113; DOI=10.1034/j.1399-0039.1999.530613.x;
RA   Luo M., Blanchard J., Maclean I., Brunham R.;
RT   "Identification of a novel HLA-DQA1 allele (DQA1*0106) by sequence-
RT   based DQA1 typing.";
RL   Tissue Antigens 53:595-596(1999).
RN   [28]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 35-74 (ALLELE DQA1*05:02).
RX   PubMed=1362295; DOI=10.1111/j.1399-0039.1992.tb02050.x;
RA   Marsh S.G., Bodomer J.G.;
RT   "HLA class II nucleotide sequences, 1992.";
RL   Tissue Antigens 40:229-243(1992).
RN   [29]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-254 (ALLELE DQA1*05:01).
RX   PubMed=3129499;
RA   Liu C.P., Bach F.H., Wu S.K.;
RT   "Molecular studies of a rare DR2/LD-5a/DQw3 HLA class II haplotype.
RT   Multiple genetic mechanisms in the generation of polymorphic HLA class
RT   II genes.";
RL   J. Immunol. 140:3631-3639(1988).
RN   [30]
RP   ERRATUM.
RA   Liu C.P., Bach F.H., Wu S.K.;
RL   J. Immunol. 144:15441-15441(1990).
RN   [31]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 40-254 (ALLELE DQA1*03:01).
RX   PubMed=6815651; DOI=10.1073/pnas.79.20.6337;
RA   Auffray C., Korman A.J., Roux-Dosseto M., Bono R., Strominger J.L.;
RT   "cDNA clone for the heavy chain of the human B cell alloantigen DC1:
RT   strong sequence homology to the HLA-DR heavy chain.";
RL   Proc. Natl. Acad. Sci. U.S.A. 79:6337-6341(1982).
RN   [32]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-102 (ALLELE DQA1*05:01), AND
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 41-103 (ALLELE DQA1*01:02).
RX   PubMed=2513578; DOI=10.1073/pnas.86.24.9986;
RA   Gyllensten U.B., Erlich H.A.;
RT   "Ancient roots for polymorphism at the HLA-DQ alpha locus in
RT   primates.";
RL   Proc. Natl. Acad. Sci. U.S.A. 86:9986-9990(1989).
RN   [33]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 119-254 (ALLELE DQA1*01:02).
RX   PubMed=2888727; DOI=10.1007/BF00346523;
RA   Turco E., Care A., Compagnone-Post P., Robinson C., Cascino I.,
RA   Trucco M.;
RT   "Allelic forms of the alpha- and beta-chain genes encoding DQw1-
RT   positive heterodimers.";
RL   Immunogenetics 26:282-290(1987).
RN   [34]
RP   REVIEW.
RX   PubMed=8598037; DOI=10.1016/S0092-8674(00)81025-9;
RA   Cresswell P.;
RT   "Invariant chain structure and MHC class II function.";
RL   Cell 84:505-507(1996).
RN   [35]
RP   REVIEW.
RX   PubMed=11684289; DOI=10.1016/S0161-5890(01)00069-4;
RA   Villadangos J.A.;
RT   "Presentation of antigens by MHC class II molecules: getting the most
RT   out of them.";
RL   Mol. Immunol. 38:329-346(2001).
RN   [36]
RP   REVIEW.
RX   PubMed=17241953; DOI=10.1016/j.immuni.2007.01.005;
RA   Menendez-Benito V., Neefjes J.;
RT   "Autophagy in MHC class II presentation: sampling from within.";
RL   Immunity 26:1-3(2007).
RN   [37]
RP   REVIEW.
RX   PubMed=18046453; DOI=10.1038/sj.emboj.7601945;
RA   Rocha N., Neefjes J.;
RT   "MHC class II molecules on the move for successful antigen
RT   presentation.";
RL   EMBO J. 27:1-5(2008).
RN   [38]
RP   REVIEW.
RX   PubMed=19092054; DOI=10.1242/jcs.035089;
RA   Berger A.C., Roche P.A.;
RT   "MHC class II transport at a glance.";
RL   J. Cell Sci. 122:1-4(2009).
RN   [39]
RP   REVIEW.
RX   PubMed=19533806; DOI=10.3748/wjg.15.2855;
RA   Beswick E.J., Reyes V.E.;
RT   "CD74 in antigen presentation, inflammation, and cancers of the
RT   gastrointestinal tract.";
RL   World J. Gastroenterol. 15:2855-2861(2009).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 27-207 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER IN COMPLEX WITH INS PEPTIDE, SUBUNIT, GLYCOSYLATION AT
RP   ASN-103, AND DISULFIDE BOND.
RX   PubMed=11376336; DOI=10.1038/88694;
RA   Lee K.H., Wucherpfennig K.W., Wiley D.C.;
RT   "Structure of a human insulin peptide-HLA-DQ8 complex and
RT   susceptibility to type 1 diabetes.";
RL   Nat. Immunol. 2:501-507(2001).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 24-219 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER (HLA-DQ0602) IN COMPLEX WITH HCRT PEPTIDE, POLYMORPHISM,
RP   SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=14769912; DOI=10.1073/pnas.0308458100;
RA   Siebold C., Hansen B.E., Wyer J.R., Harlos K., Esnouf R.E.,
RA   Svejgaard A., Bell J.I., Strominger J.L., Jones E.Y., Fugger L.;
RT   "Crystal structure of HLA-DQ0602 that protects against type 1 diabetes
RT   and confers strong susceptibility to narcolepsy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:1999-2004(2004).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.22 ANGSTROMS) OF 24-216 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER (DQ2) IN COMPLEX WITH TRITICUM AESTIVUM ALPHA/BETA-GLIADIN
RP   PEPTIDE, SUBUNIT, AND POLYMORPHISM.
RX   PubMed=15020763; DOI=10.1073/pnas.0306885101;
RA   Kim C.Y., Quarsten H., Bergseng E., Khosla C., Sollid L.M.;
RT   "Structural basis for HLA-DQ2-mediated presentation of gluten epitopes
RT   in celiac disease.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:4175-4179(2004).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 24-206 OF HLA-DQA1/HLA-DQB1
RP   HETERODIMER IN COMPLEX WITH TRITICUM AESTIVUM ALPHA/BETA-GLIADIN,
RP   SUBUNIT, AND DISULFIDE BOND.
RX   PubMed=17629515; DOI=10.1016/j.immuni.2007.05.015;
RA   Henderson K.N., Tye-Din J.A., Reid H.H., Chen Z., Borg N.A.,
RA   Beissbarth T., Tatham A., Mannering S.I., Purcell A.W., Dudek N.L.,
RA   van Heel D.A., McCluskey J., Rossjohn J., Anderson R.P.;
RT   "A structural and immunological basis for the role of human leukocyte
RT   antigen DQ8 in celiac disease.";
RL   Immunity 27:23-34(2007).
CC   -!- FUNCTION: Binds peptides derived from antigens that access the
CC       endocytic route of antigen presenting cells (APC) and presents
CC       them on the cell surface for recognition by the CD4 T-cells. The
CC       peptide binding cleft accommodates peptides of 10-30 residues. The
CC       peptides presented by MHC class II molecules are generated mostly
CC       by degradation of proteins that access the endocytic route, where
CC       they are processed by lysosomal proteases and other hydrolases.
CC       Exogenous antigens that have been endocytosed by the APC are thus
CC       readily available for presentation via MHC II molecules, and for
CC       this reason this antigen presentation pathway is usually referred
CC       to as exogenous. As membrane proteins on their way to degradation
CC       in lysosomes as part of their normal turn-over are also contained
CC       in the endosomal/lysosomal compartments, exogenous antigens must
CC       compete with those derived from endogenous components. Autophagy
CC       is also a source of endogenous peptides, autophagosomes
CC       constitutively fuse with MHC class II loading compartments. In
CC       addition to APCs, other cells of the gastrointestinal tract, such
CC       as epithelial cells, express MHC class II molecules and CD74 and
CC       act as APCs, which is an unusual trait of the GI tract. To produce
CC       a MHC class II molecule that presents an antigen, three MHC class
CC       II molecules (heterodimers of an alpha and a beta chain) associate
CC       with a CD74 trimer in the ER to form a heterononamer. Soon after
CC       the entry of this complex into the endosomal/lysosomal system
CC       where antigen processing occurs, CD74 undergoes a sequential
CC       degradation by various proteases, including CTSS and CTSL, leaving
CC       a small fragment termed CLIP (class-II-associated invariant chain
CC       peptide). The removal of CLIP is facilitated by HLA-DM via direct
CC       binding to the alpha-beta-CLIP complex so that CLIP is released.
CC       HLA-DM stabilizes MHC class II molecules until primary high
CC       affinity antigenic peptides are bound. The MHC II molecule bound
CC       to a peptide is then transported to the cell membrane surface. In
CC       B-cells, the interaction between HLA-DM and MHC class II molecules
CC       is regulated by HLA-DO. Primary dendritic cells (DCs) also to
CC       express HLA-DO. Lysosomal microenvironment has been implicated in
CC       the regulation of antigen loading into MHC II molecules, increased
CC       acidification produces increased proteolysis and efficient peptide
CC       loading.
CC   -!- SUBUNIT: Heterodimer of an alpha and a beta subunit; also referred
CC       as MHC class II molecule. In the endoplasmic reticulum (ER) it
CC       forms a heterononamer; 3 MHC class II molecules bind to a CD74
CC       homotrimer (also known as invariant chain or HLA class II
CC       histocompatibility antigen gamma chain). In the
CC       endosomal/lysosomal system; CD74 undergoes sequential degradation
CC       by various proteases; leaving a small fragment termed CLIP on each
CC       MHC class II molecule. MHC class II molecule interacts with
CC       HLA_DM, and HLA_DO in B-cells, in order to release CLIP and
CC       facilitate the binding of antigenic peptides.
CC       {ECO:0000269|PubMed:11376336, ECO:0000269|PubMed:14769912,
CC       ECO:0000269|PubMed:15020763, ECO:0000269|PubMed:17629515}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein. Endoplasmic reticulum membrane; Single-pass type I
CC       membrane protein. Golgi apparatus, trans-Golgi network membrane;
CC       Single-pass type I membrane protein. Endosome membrane; Single-
CC       pass type I membrane protein. Lysosome membrane; Single-pass type
CC       I membrane protein. Note=The MHC class II complex transits through
CC       a number of intracellular compartments in the endocytic pathway
CC       until it reaches the cell membrane for antigen presentation.
CC   -!- POLYMORPHISM: The following alleles of DQA1 are known: DQA1*01:01,
CC       DQA1*01:02, DQA1*01:03, DQA1*01:04, DQA1*01:05, DQA1*01:06,
CC       DQA1*01:07, DQA1*02:01, DQA1*03:01, DQA1*03:02, DQA1*03:03,
CC       DQA1*04:01, DQA1*04:02, DQA1*04:03, DQA1*04:04, DQA1*05:01,
CC       DQA1*05:02, DQA1*05:03, DQA1*05:04, DQA1*05:05, DQA1*05:06,
CC       DQA1*05:07, DQA1*05:08, DQA1*05:09, DQA1*06:01, DQA1*06:02. The
CC       sequence shown is that of DQA1*05:01.
CC   -!- POLYMORPHISM: DQ2 (heterodimer of DQA1*05:01/DQB1*02:01) is
CC       associated with more than 90% of celiac disease patients. A
CC       minority displays DQ8 (heterodimer of DQA1*03/DQB1*03:02). DQ0602
CC       (heterodimer of DQA1*01:02/DQB1*06:02) confers dominant protection
CC       against type 1 diabetes (T1D) and strong susceptibility to
CC       narcolepsy.
CC   -!- SIMILARITY: Belongs to the MHC class II family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 Ig-like C1-type (immunoglobulin-like)
CC       domain. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD56720.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X00033; CAA24917.1; -; mRNA.
DR   EMBL; X00370; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; X00452; CAA25141.1; -; mRNA.
DR   EMBL; M16995; AAA59760.1; -; mRNA.
DR   EMBL; U92032; AAB91990.1; -; Genomic_DNA.
DR   EMBL; AY663395; AAU87978.1; -; Genomic_DNA.
DR   EMBL; AY663398; AAU87987.1; -; Genomic_DNA.
DR   EMBL; AY663400; AAU87992.1; -; Genomic_DNA.
DR   EMBL; AY663406; AAU88007.1; -; Genomic_DNA.
DR   EMBL; AY663411; AAU88022.1; -; Genomic_DNA.
DR   EMBL; AY663413; AAU88028.1; -; Genomic_DNA.
DR   EMBL; DQ178403; ABA86855.1; -; Genomic_DNA.
DR   EMBL; DQ178400; ABA86855.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178401; ABA86855.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178402; ABA86855.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178407; ABA86856.1; -; Genomic_DNA.
DR   EMBL; DQ178404; ABA86856.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178405; ABA86856.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178406; ABA86856.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178411; ABA86857.1; -; Genomic_DNA.
DR   EMBL; DQ178408; ABA86857.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178409; ABA86857.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178410; ABA86857.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178415; ABA86858.1; -; Genomic_DNA.
DR   EMBL; DQ178412; ABA86858.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178413; ABA86858.1; JOINED; Genomic_DNA.
DR   EMBL; DQ178414; ABA86858.1; JOINED; Genomic_DNA.
DR   EMBL; M29616; AAA59759.1; -; Genomic_DNA.
DR   EMBL; M29613; AAA59759.1; JOINED; Genomic_DNA.
DR   EMBL; AF322870; AAK11577.1; -; Genomic_DNA.
DR   EMBL; AF322867; AAK11577.1; JOINED; Genomic_DNA.
DR   EMBL; AF322868; AAK11577.1; JOINED; Genomic_DNA.
DR   EMBL; AF322869; AAK11577.1; JOINED; Genomic_DNA.
DR   EMBL; AF395700; AAM69677.1; -; Genomic_DNA.
DR   EMBL; AF395697; AAM69677.1; JOINED; Genomic_DNA.
DR   EMBL; AF395698; AAM69677.1; JOINED; Genomic_DNA.
DR   EMBL; AF395699; AAM69677.1; JOINED; Genomic_DNA.
DR   EMBL; CR450297; CAG29293.1; -; mRNA.
DR   EMBL; AM042559; CAJ14960.1; -; Genomic_DNA.
DR   EMBL; AM042560; CAJ14961.1; -; Genomic_DNA.
DR   EMBL; AK313975; BAG36689.1; -; mRNA.
DR   EMBL; BX248406; CAM26191.1; -; Genomic_DNA.
DR   EMBL; AL662789; CAI18230.1; -; Genomic_DNA.
DR   EMBL; Z84489; CAB06491.1; -; Genomic_DNA.
DR   EMBL; BC008585; AAH08585.1; -; mRNA.
DR   EMBL; BC157865; AAI57866.1; -; mRNA.
DR   EMBL; L46875; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46876; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46877; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46878; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46880; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; L46881; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M11124; AAA59754.1; -; mRNA.
DR   EMBL; M20431; AAA59758.1; -; mRNA.
DR   EMBL; L34082; AAC41950.1; -; mRNA.
DR   EMBL; L34085; AAC41953.1; -; mRNA.
DR   EMBL; L34086; AAC41954.1; -; mRNA.
DR   EMBL; L34089; AAC41957.1; -; mRNA.
DR   EMBL; L34090; AAC41958.1; -; mRNA.
DR   EMBL; L34092; AAC41960.1; -; mRNA.
DR   EMBL; L34093; AAC41961.1; -; mRNA.
DR   EMBL; L34094; AAC41962.1; -; mRNA.
DR   EMBL; L42625; AAA85334.1; -; mRNA.
DR   EMBL; AY197775; AAO45622.1; -; Genomic_DNA.
DR   EMBL; AY547314; AAS49496.1; -; Genomic_DNA.
DR   EMBL; AY206406; AAO47362.1; -; Genomic_DNA.
DR   EMBL; AY585236; AAT09985.1; -; Genomic_DNA.
DR   EMBL; M34997; AAA35772.1; -; Genomic_DNA.
DR   EMBL; M34999; AAA74633.1; -; Genomic_DNA.
DR   EMBL; U85035; AAB41891.1; -; Genomic_DNA.
DR   EMBL; AF109734; AAD56720.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; U03675; AAB60341.1; -; Genomic_DNA.
DR   EMBL; M20506; AAA59774.1; -; mRNA.
DR   EMBL; J00199; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; M17846; AAA59707.1; -; mRNA.
DR   PIR; A02211; HLHUD1.
DR   PIR; A02213; HLHUDQ.
DR   PIR; A02214; HLHUD7.
DR   PIR; A02215; HLHU3C.
DR   PIR; A93326; HLHUDC.
DR   PIR; B27628; B27628.
DR   PIR; D34512; D34512.
DR   RefSeq; NP_002113.2; NM_002122.3.
DR   RefSeq; XP_005275010.1; XM_005274953.3.
DR   RefSeq; XP_005275165.1; XM_005275108.3.
DR   RefSeq; XP_005275599.1; XM_005275542.3.
DR   RefSeq; XP_006725547.1; XM_006725484.2.
DR   RefSeq; XP_006726062.1; XM_006725999.2.
DR   UniGene; Hs.387679; -.
DR   UniGene; Hs.591798; -.
DR   UniGene; Hs.706240; -.
DR   PDB; 1JK8; X-ray; 2.40 A; A=27-206.
DR   PDB; 1NBN; Model; -; A=27-206.
DR   PDB; 1S9V; X-ray; 2.22 A; A/D=24-216.
DR   PDB; 1UVQ; X-ray; 1.80 A; A=24-218.
DR   PDB; 2NNA; X-ray; 2.10 A; A=24-206.
DR   PDB; 4GG6; X-ray; 3.20 A; A/C=24-206.
DR   PDB; 4OZF; X-ray; 2.70 A; A=24-206.
DR   PDB; 4OZG; X-ray; 3.00 A; A/C=24-206.
DR   PDB; 4OZH; X-ray; 2.80 A; A/C=24-206.
DR   PDB; 4OZI; X-ray; 3.20 A; A/C=24-206.
DR   PDBsum; 1JK8; -.
DR   PDBsum; 1NBN; -.
DR   PDBsum; 1S9V; -.
DR   PDBsum; 1UVQ; -.
DR   PDBsum; 2NNA; -.
DR   PDBsum; 4GG6; -.
DR   PDBsum; 4OZF; -.
DR   PDBsum; 4OZG; -.
DR   PDBsum; 4OZH; -.
DR   PDBsum; 4OZI; -.
DR   ProteinModelPortal; P01909; -.
DR   SMR; P01909; 27-205.
DR   BioGrid; 109362; 23.
DR   IntAct; P01909; 11.
DR   BioMuta; HLA-DQA1; -.
DR   DMDM; 122188; -.
DR   PaxDb; P01909; -.
DR   PRIDE; P01909; -.
DR   DNASU; 3117; -.
DR   Ensembl; ENST00000343139; ENSP00000339398; ENSG00000196735.
DR   Ensembl; ENST00000374949; ENSP00000364087; ENSG00000196735.
DR   Ensembl; ENST00000383251; ENSP00000372738; ENSG00000206305.
DR   Ensembl; ENST00000395363; ENSP00000378767; ENSG00000196735.
DR   Ensembl; ENST00000399675; ENSP00000382583; ENSG00000206305.
DR   Ensembl; ENST00000399678; ENSP00000382586; ENSG00000206305.
DR   Ensembl; ENST00000418023; ENSP00000387892; ENSG00000232062.
DR   Ensembl; ENST00000444296; ENSP00000413237; ENSG00000232062.
DR   Ensembl; ENST00000548014; ENSP00000447970; ENSG00000206305.
DR   GeneID; 3117; -.
DR   KEGG; hsa:3117; -.
DR   UCSC; uc011fnq.1; human.
DR   CTD; 3117; -.
DR   GeneCards; GC06P032595; -.
DR   GeneCards; GC06Pn32538; -.
DR   GeneCards; GC06Po32698; -.
DR   GeneReviews; HLA-DQA1; -.
DR   HGNC; HGNC:4942; HLA-DQA1.
DR   HPA; HPA012315; -.
DR   MIM; 146880; gene.
DR   neXtProt; NX_P01909; -.
DR   Orphanet; 555; Celiac disease.
DR   Orphanet; 243377; Diabetes mellitus type 1.
DR   Orphanet; 930; Idiopathic achalasia.
DR   PharmGKB; PA35066; -.
DR   eggNOG; NOG26577; -.
DR   HOVERGEN; HBG006862; -.
DR   InParanoid; P01909; -.
DR   KO; K06752; -.
DR   OMA; KETVWCL; -.
DR   PhylomeDB; P01909; -.
DR   TreeFam; TF333797; -.
DR   Reactome; REACT_121399; MHC class II antigen presentation.
DR   Reactome; REACT_12555; Downstream TCR signaling.
DR   Reactome; REACT_12582; Phosphorylation of CD3 and TCR zeta chains.
DR   Reactome; REACT_12596; Translocation of ZAP-70 to Immunological synapse.
DR   Reactome; REACT_12623; Generation of second messenger molecules.
DR   Reactome; REACT_19324; PD-1 signaling.
DR   Reactome; REACT_25078; Interferon gamma signaling.
DR   ChiTaRS; HLA-DQA1; human.
DR   EvolutionaryTrace; P01909; -.
DR   NextBio; 12366; -.
DR   PRO; PR:P01909; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; P01909; -.
DR   CleanEx; HS_HLA-DQA1; -.
DR   ExpressionAtlas; P01909; baseline and differential.
DR   Genevisible; P01909; HS.
DR   GO; GO:0030669; C:clathrin-coated endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0030666; C:endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0012507; C:ER to Golgi transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0000139; C:Golgi membrane; TAS:Reactome.
DR   GO; GO:0071556; C:integral component of lumenal side of endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005765; C:lysosomal membrane; TAS:Reactome.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0042613; C:MHC class II protein complex; ISS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0030658; C:transport vesicle membrane; TAS:Reactome.
DR   GO; GO:0032395; F:MHC class II receptor activity; NAS:UniProtKB.
DR   GO; GO:0042605; F:peptide antigen binding; ISS:UniProtKB.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0019221; P:cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0006955; P:immune response; NAS:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0031295; P:T cell costimulation; TAS:Reactome.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; TAS:Reactome.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.10.320.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003006; Ig/MHC_CS.
DR   InterPro; IPR003597; Ig_C1-set.
DR   InterPro; IPR011162; MHC_I/II-like_Ag-recog.
DR   InterPro; IPR014745; MHC_II_a/b_N.
DR   InterPro; IPR001003; MHC_II_a_N.
DR   Pfam; PF07654; C1-set; 1.
DR   Pfam; PF00993; MHC_II_alpha; 1.
DR   SMART; SM00407; IGc1; 1.
DR   SMART; SM00920; MHC_II_alpha; 1.
DR   SUPFAM; SSF54452; SSF54452; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00290; IG_MHC; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Disulfide bond; Endoplasmic reticulum;
KW   Endosome; Glycoprotein; Golgi apparatus; Immunity; Lysosome; Membrane;
KW   MHC II; Polymorphism; Reference proteome; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000269|PubMed:6576979}.
FT   CHAIN        24    254       HLA class II histocompatibility antigen,
FT                                DQ alpha 1 chain.
FT                                /FTId=PRO_0000018970.
FT   TOPO_DOM     24    216       Extracellular. {ECO:0000255}.
FT   TRANSMEM    217    239       Helical. {ECO:0000255}.
FT   TOPO_DOM    240    254       Cytoplasmic.
FT   DOMAIN      112    204       Ig-like C1-type.
FT   REGION       24    119       Alpha-1.
FT   REGION      120    203       Alpha-2.
FT   REGION      204    216       Connecting peptide.
FT   CARBOHYD    103    103       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    143    143       N-linked (GlcNAc...). {ECO:0000255}.
FT   DISULFID    132    188       {ECO:0000255|PROSITE-ProRule:PRU00114,
FT                                ECO:0000269|PubMed:11376336,
FT                                ECO:0000269|PubMed:14769912,
FT                                ECO:0000269|PubMed:17629515}.
FT   VARIANT       8      8       M -> L (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*04:01 and allele DQA1*06:01;
FT                                dbSNP:rs1047989).
FT                                /FTId=VAR_033399.
FT   VARIANT      11     11       A -> T (in allele DQA1*05:05, allele
FT                                DQA1*05:08 and allele DQA1*05:09;
FT                                dbSNP:rs1047992).
FT                                /FTId=VAR_033400.
FT   VARIANT      17     17       V -> M (in allele DQA1*01:04 and allele
FT                                DQA1*01:05; dbSNP:rs12722039).
FT                                /FTId=VAR_050380.
FT   VARIANT      18     18       M -> T (in allele DQA1*03:03;
FT                                dbSNP:rs12722040).
FT                                /FTId=VAR_050381.
FT   VARIANT      24     24       E -> K (in allele DQA1*05:09;
FT                                dbSNP:rs41545012).
FT                                /FTId=VAR_060493.
FT   VARIANT      25     25       D -> G (in allele DQA1*01:04 and allele
FT                                DQA1*01:05; dbSNP:rs12722042).
FT                                /FTId=VAR_050382.
FT   VARIANT      34     34       Y -> C (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1129740).
FT                                /FTId=VAR_060494.
FT   VARIANT      41     41       S -> F (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1071630).
FT                                /FTId=VAR_033401.
FT   VARIANT      44     44       P -> L (in allele DQA1*05:04;
FT                                dbSNP:rs41549715).
FT                                /FTId=VAR_060495.
FT   VARIANT      48     48       Y -> F (in allele DQA1*02:01, allele
FT                                DQA1*01:03, allele DQA1*06:01 and allele
FT                                DQA1*06:02; dbSNP:rs12722051).
FT                                /FTId=VAR_033402.
FT   VARIANT      49     49       T -> S (in allele DQA1*03:01, allele
FT                                DQA1*03:02 and allele DQA1*03:03;
FT                                dbSNP:rs3188011).
FT                                /FTId=VAR_033403.
FT   VARIANT      57     57       Q -> E (in allele DQA1*01:01, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:07, allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02 and allele
FT                                DQA1*03:03; dbSNP:rs10093).
FT                                /FTId=VAR_014604.
FT   VARIANT      63     63       G -> E (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06, allele DQA1*01:07, allele
FT                                DQA1*02:01, allele DQA1*03:01, allele
FT                                DQA1*03:02 and allele DQA1*03:03;
FT                                dbSNP:rs1142323).
FT                                /FTId=VAR_060496.
FT   VARIANT      64     64       R -> K (in allele DQA1*01:03;
FT                                dbSNP:rs36219699).
FT                                /FTId=VAR_050383.
FT   VARIANT      67     67       T -> A (in allele DQA1*01:06;
FT                                dbSNP:rs41543221).
FT                                /FTId=VAR_060497.
FT   VARIANT      68     68       V -> A (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1142324).
FT                                /FTId=VAR_060498.
FT   VARIANT      70     70       C -> K (in allele DQA1*02:01; requires 2
FT                                nucleotide substitutions).
FT                                /FTId=VAR_060499.
FT   VARIANT      70     70       C -> Q (in allele DQA1*03:01, allele
FT                                DQA1*03:02 and allele DQA1*03:03;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_060500.
FT   VARIANT      70     70       C -> R (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07).
FT                                /FTId=VAR_060501.
FT   VARIANT      70     70       C -> Y (in dbSNP:rs3207983).
FT                                /FTId=VAR_033404.
FT   VARIANT      71     71       L -> W (in allele DQA1*01:01, allele
FT                                DQA1*01:02,allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1142328).
FT                                /FTId=VAR_060502.
FT   VARIANT      73     73       V -> D.
FT                                /FTId=VAR_033406.
FT   VARIANT      73     73       V -> E (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs3208105).
FT                                /FTId=VAR_060503.
FT   VARIANT      73     73       V -> L (in allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02 and allele
FT                                DQA1*03:03).
FT                                /FTId=VAR_033405.
FT   VARIANT      74     74       L -> F (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06, allele DQA1*01:07, allele
FT                                DQA1*02:01, allele DQA1*03:01, allele
FT                                DQA1*03:02 and allele DQA1*03:03;
FT                                dbSNP:rs9272698).
FT                                /FTId=VAR_060504.
FT   VARIANT      75     75       R -> H (in allele DQA1*02:01).
FT                                /FTId=VAR_060505.
FT   VARIANT      75     75       R -> S (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs9272699).
FT                                /FTId=VAR_060506.
FT   VARIANT      76     76       Q -> K (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1048052).
FT                                /FTId=VAR_060507.
FT   VARIANT      76     76       Q -> R (in allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02 and allele
FT                                DQA1*03:03).
FT                                /FTId=VAR_060508.
FT   VARIANT      77     77       F -> L (in allele DQA1*02:01;
FT                                dbSNP:rs3188043).
FT                                /FTId=VAR_060509.
FT   VARIANT      78     78       R -> GG (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05,allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs4193).
FT                                /FTId=VAR_060510.
FT   VARIANT      78     78       R -> RR (in allele DQA1*03:01, allele
FT                                DQA1*03:02 and allele DQA1*03:03).
FT                                /FTId=VAR_060511.
FT   VARIANT      78     78       R -> S (in dbSNP:rs36219345).
FT                                /FTId=VAR_033407.
FT   VARIANT      81     81       P -> R (in allele DQA1*05:02;
FT                                dbSNP:rs41541412).
FT                                /FTId=VAR_060512.
FT   VARIANT      83     83       F -> G (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_060513.
FT   VARIANT      86     86       T -> R (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1048073).
FT                                /FTId=VAR_033408.
FT   VARIANT      88     88       I -> M (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1048080).
FT                                /FTId=VAR_033409.
FT   VARIANT      91     91       L -> A (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_060514.
FT   VARIANT      91     91       L -> T (in allele DQA1*04:01, allele
FT                                DQA1*04:02, allele DQA1*04:04, allele
FT                                DQA1*06:01 and allele DQA1*06:02;
FT                                requires 2 nucleotide substitutions).
FT                                /FTId=VAR_060515.
FT   VARIANT      91     91       L -> V (in dbSNP:rs1048085).
FT                                /FTId=VAR_033410.
FT   VARIANT      97     97       S -> I (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06, allele DQA1*01:07, allele
FT                                DQA1*02:01, allele DQA1*03:01, allele
FT                                DQA1*03:02, allele DQA1*03:03, allele
FT                                DQA1*04:01, allele DQA1*04:02, allele
FT                                DQA1*04:04, allele DQA1*06:01 and allele
FT                                DQA1*06:02).
FT                                /FTId=VAR_060516.
FT   VARIANT      98     98       L -> M (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07).
FT                                /FTId=VAR_060517.
FT   VARIANT      98     98       L -> V (in allele DQA1*03:01, allele
FT                                DQA1*03:02 and allele DQA1*03:03).
FT                                /FTId=VAR_060518.
FT   VARIANT     101    101       R -> C (in allele DQA1*01:07).
FT                                /FTId=VAR_060519.
FT   VARIANT     102    102       S -> Y (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:06 and allele DQA1*01:07;
FT                                dbSNP:rs1129808).
FT                                /FTId=VAR_050384.
FT   VARIANT     124    124       L -> V (in allele DQA1*05:06).
FT                                /FTId=VAR_060520.
FT   VARIANT     129    129       I -> T (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:07, allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02, allele
FT                                DQA1*03:03, allele DQA1*04:01, allele
FT                                DQA1*04:02, allele DQA1*04:04, allele
FT                                DQA1*06:01 and allele DQA1*06:02;
FT                                dbSNP:rs707952).
FT                                /FTId=VAR_050385.
FT   VARIANT     151    151       H -> Q (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:04, allele
FT                                DQA1*01:05 and allele DQA1*01:07;
FT                                dbSNP:rs707950).
FT                                /FTId=VAR_050386.
FT   VARIANT     152    152       S -> A (in allele DQA1*01:03).
FT                                /FTId=VAR_060521.
FT   VARIANT     160    160       T -> I (in allele DQA1*04:02).
FT                                /FTId=VAR_060522.
FT   VARIANT     161    161       S -> I (in allele DQA1*05:08).
FT                                /FTId=VAR_060524.
FT   VARIANT     161    161       S -> R (in allele DQA1*06:02).
FT                                /FTId=VAR_060523.
FT   VARIANT     175    175       Y -> H (in allele DQA1*04:04).
FT                                /FTId=VAR_060525.
FT   VARIANT     178    178       L -> F (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:07, allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02, allele
FT                                DQA1*03:03, allele DQA1*04:01, allele
FT                                DQA1*04:02, allele DQA1*04:04, allele
FT                                DQA1*06:01 and allele DQA1*06:02;
FT                                dbSNP:rs707949).
FT                                /FTId=VAR_060526.
FT   VARIANT     182    182       A -> D (in allele DQA1*03:02 and allele
FT                                DQA1*03:03).
FT                                /FTId=VAR_060527.
FT   VARIANT     182    182       A -> S (in allele DQA1*05:03, allele
FT                                DQA1*05:06 and allele DQA1*05:07).
FT                                /FTId=VAR_060528.
FT   VARIANT     183    183       E -> D (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:07, allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02, allele
FT                                DQA1*03:03, allele DQA1*04:01, allele
FT                                DQA1*04:02, allele DQA1*04:04, allele
FT                                DQA1*06:01 and allele DQA1*06:02;
FT                                dbSNP:rs707963).
FT                                /FTId=VAR_060529.
FT   VARIANT     185    185       S -> I (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05, allele
FT                                DQA1*01:07, allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02, allele
FT                                DQA1*03:03, allele DQA1*04:01, allele
FT                                DQA1*04:02, allele DQA1*04:04, allele
FT                                DQA1*06:01 and allele DQA1*06:02).
FT                                /FTId=VAR_060530.
FT   VARIANT     197    197       K -> E (in allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02, allele
FT                                DQA1*03:03, allele DQA1*04:01, allele
FT                                DQA1*04:02, allele DQA1*04:04, allele
FT                                DQA1*06:01 and allele DQA1*06:02).
FT                                /FTId=VAR_060531.
FT   VARIANT     197    197       K -> Q (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04, allele DQA1*01:05 and allele
FT                                DQA1*01:07).
FT                                /FTId=VAR_060532.
FT   VARIANT     209    209       A -> T (in allele DQA1*03:01, allele
FT                                DQA1*03:02 and allele DQA1*03:03;
FT                                dbSNP:rs9272785).
FT                                /FTId=VAR_050387.
FT   VARIANT     221    221       A -> T (in allele DQA1*01:04;
FT                                dbSNP:rs35087390).
FT                                /FTId=VAR_050388.
FT   VARIANT     229    229       V -> M (in allele DQA1*01:02;
FT                                dbSNP:rs9260).
FT                                /FTId=VAR_033411.
FT   VARIANT     230    230       G -> C (in allele DQA1*05:07).
FT                                /FTId=VAR_060533.
FT   VARIANT     237    237       F -> L (in allele DQA1*02:01, allele
FT                                DQA1*03:01, allele DQA1*03:02 and allele
FT                                DQA1*03:03; dbSNP:rs1048430).
FT                                /FTId=VAR_033412.
FT   VARIANT     240    240       R -> Q (in allele DQA1*01:01, allele
FT                                DQA1*01:02, allele DQA1*01:03, allele
FT                                DQA1*01:04 and allele DQA1*01:05;
FT                                dbSNP:rs9272793).
FT                                /FTId=VAR_033413.
FT   CONFLICT     11     11       A -> S (in Ref. 4; AAA59760).
FT                                {ECO:0000305}.
FT   CONFLICT     23     27       Missing (in Ref. 16; AAA59754).
FT                                {ECO:0000305}.
FT   CONFLICT     91     91       L -> H (in Ref. 4; AAA59760).
FT                                {ECO:0000305}.
FT   CONFLICT    107    107       A -> P (in Ref. 16; AAA59754).
FT                                {ECO:0000305}.
FT   CONFLICT    156    156       G -> D (in Ref. 3; CAA25141).
FT                                {ECO:0000305}.
FT   CONFLICT    213    213       E -> D (in Ref. 16; AAA59754).
FT                                {ECO:0000305}.
FT   STRAND       29     40       {ECO:0000244|PDB:1UVQ}.
FT   TURN         41     44       {ECO:0000244|PDB:1UVQ}.
FT   STRAND       45     52       {ECO:0000244|PDB:1UVQ}.
FT   STRAND       55     61       {ECO:0000244|PDB:1UVQ}.
FT   TURN         62     65       {ECO:0000244|PDB:1UVQ}.
FT   STRAND       66     68       {ECO:0000244|PDB:1UVQ}.
FT   HELIX        72     77       {ECO:0000244|PDB:1UVQ}.
FT   HELIX        81    101       {ECO:0000244|PDB:1UVQ}.
FT   TURN        102    104       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      113    120       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      124    126       {ECO:0000244|PDB:4OZF}.
FT   STRAND      128    137       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      143    148       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      151    153       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      157    159       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      170    178       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      186    191       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      195    197       {ECO:0000244|PDB:1UVQ}.
FT   STRAND      199    202       {ECO:0000244|PDB:1UVQ}.
SQ   SEQUENCE   254 AA;  27805 MW;  84E12B5A80E2A028 CRC64;
     MILNKALMLG ALALTTVMSP CGGEDIVADH VASYGVNLYQ SYGPSGQYTH EFDGDEQFYV
     DLGRKETVWC LPVLRQFRFD PQFALTNIAV LKHNLNSLIK RSNSTAATNE VPEVTVFSKS
     PVTLGQPNIL ICLVDNIFPP VVNITWLSNG HSVTEGVSET SFLSKSDHSF FKISYLTLLP
     SAEESYDCKV EHWGLDKPLL KHWEPEIPAP MSELTETVVC ALGLSVGLVG IVVGTVFIIR
     GLRSVGASRH QGPL
//
